| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.053 | 0.08 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.08 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.08 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.068 | 0.08 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.08 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.09 |